These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6146422)

  • 1. Effects of medroxalol on renal function and the renin-angiotensin-aldosterone axis.
    Wallin JD; Jones P; O'Neill WM; Kuzma RJ; Morgan RJ; Morgan M; Rolf C
    Clin Pharmacol Ther; 1984 Aug; 36(2):169-73. PubMed ID: 6146422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
    Greven J; Gabriëls G
    Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral contraceptives on the renin angiotensin system and renal function.
    Kang AK; Duncan JA; Cattran DC; Floras JS; Lai V; Scholey JW; Miller JA
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R807-13. PubMed ID: 11171661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
    Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
    Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxalol combined with hydrochlorothiazide in the treatment of hypertension.
    Vlachakis ND; Valasquez M; Alexander N; Maronde RF
    J Clin Pharmacol; 1983 Oct; 23(10):419-27. PubMed ID: 6139390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
    Elliott HL; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
    Resnick LM; Catanzaro D; Sealey JE; Laragh JH
    Am J Hypertens; 2004 Mar; 17(3):203-8. PubMed ID: 15001191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake.
    Kramer HJ; Stinnesbeck B; Klautke G; Kipnowski J; Klingmueller D; Glaenzer K; Duesing R
    Clin Sci (Lond); 1985 Apr; 68(4):387-93. PubMed ID: 3971667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pindolol on renal function.
    Wainer E; Boner G; Rosenfeld JB
    Clin Pharmacol Ther; 1980 Nov; 28(5):575-80. PubMed ID: 7002425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
    Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Visoná A; Lusiani L; Pagnan A
    Clin Pharmacol Ther; 1988 Aug; 44(2):211-6. PubMed ID: 2456174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.
    Sonkodi S; Agabiti-Rosei E; Fraser R; Leckie BJ; Morton JJ; Cumming AM; Sood VP; Robertson JI
    Br J Clin Pharmacol; 1982 Mar; 13(3):341-50. PubMed ID: 6120716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.